
Comparing Factor Use and Bleed Rates in US Hemophilia A Patients Receiving Prophylaxis With 3 Different Long-Acting Recombinant Factor VIII Products

Advertisement
Advertisement
Trending on AJMC
1
Value-Based Pilot for Medicaid Members With Substance Use Disorder
2
Four Ways to Boost Awareness, Access for COVID-19 PEP
3
Health Equity & Access Weekly Roundup: November 20, 2026
4
Acne Treatment Adherence Ranges From 6% to 84% in Real-World Studies
5